Follow us: facebook twitter linkedin
Login My ASCCP Search

The Journal of Lower Genital Tract Disease (JLGTD), the journal of the American Society for Colposcopy and Cervical Pathology (ASCCP), is the source for the latest science in diagnosis, etiology, and therapy of pathologic conditions of the cervix, vagina, and vulva. The Journal is a peer-reviewed publication for the exchange of information among interested health care providers from many different disciplines including pathology, cytology, cytogenetics, gynecologic oncology, endocrinology, preventive medicine, basic science, and clinical medicine. Features include original, peer-reviewed articles; book reviews; case reports; review articles; a Home Study Course including instructional cases with photographs; descriptions of technique/technology; and abstracts from meetings. Prestigious organizations such as The International Federation of Cervical Pathology and Colposcopy, the Australia Society, the Society of Canada and the Spanish Society have made this respected journal their official publication.

 
 



This  January, 2014 Presidents' Pick From: 
Teresa M. Darragh, MD
ASCCP President 
 
This October, 2013 Presidents' Pick From: 
Teresa M. Darragh, MD
ASCCP President 
European Twins – Changing Roles
In this issue of the Journal, I recommend a twin pair of articles on the current and future state of cervical cancer prevention in Europe by Leeson et al: "HPV Testing and Vaccination in Europe" and "The Future Role for Colposcopy in Europe." (continue reading...) 
     
Cover-to-Cover 
The current issue of the Journal of Lower Genital Disease is packed with interesting and informative articles – it is well worth reading cover-to-cover! I would like to draw your attention, in particular, to the article by Martin Steinau and colleagues titled: “Human Papillomavirus Prevalence in Invasive Anal Cancers in the United States Before Vaccine Introduction.”   (continue reading...) 



   
 
Copyright © 2014. All rights reserved.   Use of this Web site constitutes acceptance of our Terms of Use.